OHI, US6819361006

Wells Fargo cuts target for Omega Healthcare Investors stock to USD 46

Published on 10/20/2026 at 19:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results come November 4, 2026. Omega Healthcare Investors stock costs EUR 40.46 on October 20, 2026, down 0.20 percent versus Frankfurt close.

Analyst target and reporting date

Wells Fargo revised its Omega Healthcare Investors target on October 19, 2026.
Omega Healthcare Investors is scheduled to report third-quarter results on November 4, 2026.
Omega Healthcare Investors stock cost EUR 40.46 at Lang & Schwarz on October 20, 2026 at 7:03 p.m. CEST, down 0.20 percent versus the Frankfurt close of October 19, 2026 and 22.77 percent below its 52-week high.
Omega reported second-quarter revenue of USD 328.25 million and earnings per share of USD 1.19.

OHI, US6819361006, Illustration mit AI erstellt.

Wells Fargo cut its price target for Omega Healthcare Investors from USD 48 to USD 46 on October 19, 2026, while keeping an Equal Weight rating, according to Markets Insider. The new target is 1.30 percent above the USD 45.41 NYSE price reported for October 20, 2026. At Lang & Schwarz, the stock was trading at EUR 40.46 on October 20, 2026 at 7:03 p.m. CEST, down 0.20 percent versus the Frankfurt close of October 19, 2026 at EUR 40.54.

Results date keeps the calendar active

Omega Healthcare Investors is scheduled to release third-quarter 2026 results on November 4, 2026, with the conference call set for 10:00 a.m. ET, according to the company investor-relations page. The company identifies 1,108 properties, 100,588 beds and USD 11.4 billion of total real estate investments as of June 30, 2026. Its portfolio centers on skilled nursing and assisted-living facilities leased to healthcare operators.

Stock stays below its yearly high

The NYSE quote stood at USD 45.41 on October 20, 2026, against a 52-week range of USD 39.26 to USD 52.39. That places the stock 13.32 percent below its high and 15.66 percent above its low. The same quote showed a market capitalization of USD 13.8 billion, a price-to-earnings ratio of 16.22 and a trailing dividend yield of 6.00 percent.

Second-quarter figures set the benchmark

Omega reported second-quarter 2026 revenue of USD 328.25 million, up 16.20 percent from the prior-year quarter, according to MarketBeat. Reported earnings per share were USD 1.19, compared with a USD 0.51 consensus estimate, while revenue exceeded the USD 266.97 million estimate. The company investor-relations page identifies the quarter ended June 30, 2026 as its latest reported period.

Comparison with peers

Omega Healthcare Investors: down 0.20 percent versus the Frankfurt close, P/E 16.22, market capitalization USD 13.8 billion.

Healthpeak Properties (NYSE, USD): up 1.98 percent on October 20, 2026, P/E 53.61, market capitalization USD 12.9 billion.

CareTrust REIT (NYSE, USD): up 1.33 percent on October 20, 2026, P/E 22.56, market capitalization USD 8.6 billion.

Target cut meets an earnings date

For investors, the immediate tension is between a lower USD 46 target and a scheduled results date less than three weeks away. The second-quarter revenue increase and earnings-per-share comparison provide the operating benchmarks for that event, while the 6.00 percent dividend yield remains a central valuation feature.

Omega Healthcare Investors stock was trading at EUR 40.46 at Lang & Schwarz on October 20, 2026 at 7:03 p.m. CEST, down 0.20 percent versus the Frankfurt close of October 19, 2026 at EUR 40.54 and 22.77 percent below the USD 52.39 52-week high on the NYSE. The further course of trading is shown by the continuously updated real-time quote of Omega Healthcare Investors stock.